microRNA 6079 (MIR6079)

microRNA 6079 (MIR6079) is listed with nomenclature consistent with human microRNAs (hsa-mir-6079), but there is no published evidence supporting its functional role or expression as a bona fide microRNA[4][5]. Peer-reviewed articles and curated databases describing well-characterized microRNAs do not include MIR6079 in their major lists, indicating it may be an unvalidated entry or a misannotation[5]. MicroRNAs (miRNAs) are short non-coding RNAs (typically 21–23 nucleotides) involved in post-transcriptional regulation of gene expression, affecting processes such as mRNA stability, translation inhibition, and even chromatin modification[4]. However, only about 500 out of over 1,900 human miRNA annotations are considered bona fide, based on stringent criteria including conserved structure, reproducible processing, and experimental validation[5]. MIR6079 is not a recognized therapeutic target or validated microRNA. Its listing is likely due to preliminary computational prediction, lacking experimental or functional confirmation. This target should be flagged as incorrect or unsupported for further structured analysis or drug discovery work.

Other names

hsa-mir-6079microRNA mir-6079MIR6079